OpenAI-backed Red Queen Bio raises $36M for AI-designed antibody drugs

Red Queen Bio, an AI biosecurity startup backed by OpenAI, has raised $36M. The company uses AI to design antibody drugs against novel pathogens, including AI-enabled bioweapons.

• Red Queen Bio has raised $36M in funding
• The startup is backed by OpenAI
• AI is used to design antibody drugs against novel pathogens
• Goal is defense against AI-enabled bioweapons